PubMed Health. A service of the National Library of Medicine, National Institutes of Health.
A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.
A.D.A.M. Medical Encyclopedia.
Primary alveolar hypoventilation is a rare disorder of unknown cause in which a person does not take enough breaths per minute. The lungs and airways are normal.
Causes, incidence, and risk factors
Normally, when the oxygen levels in the blood are low or the carbon dioxide levels are high, there is a signal from the brain to breathe more deeply or more quickly. In people with primary alveolar hypoventilation, this change in breathing does not happen.
The cause of primary alveolar hypoventilation is unknown. Some patients have a specific genetic defect.
The disease mainly affects men 20 to 50 years old, although it may also occur in children.
Symptoms
Symptoms are usually worse during sleep, and periods of apnea (episodes of stopped breathing) are usually present. Often patients themselves do not complain of shortness of breath during the day.
Symptoms include:
- Bluish coloration of the skin caused by lack of oxygen
- Daytime drowsiness
- Morning headaches
- Swelling of the ankles
- Waking up from sleep unrested
- Waking up many times at night
Persons with this disease are extremely sensitive to even small doses of sedatives or narcotics, which can make their already inadequate breathing much worse.
Signs and tests
The health care provider will perform a physical exam. Tests will be done to rule out other causes. For example, muscular dystrophy can make the rib muscles weak, and emphysema damages the lung tissue itself. A small stroke can affect the breathing center in the brain.
Tests that may be done include:
- Blood gases
- Hematocrit and hemoglobin blood tests
- Overnight oxygen level measurements (oximetry)
- Serum bicarbonate
- Sleep study (polysomnography)
Treatment
Medications that stimulate the respiratory system may be used but do not always work. Mechanical devices that assist breathing, particularly at night, may be helpful in some patients. Oxygen therapy may be helpful in a few patients, but may cause worse night symptoms in others.
Expectations (prognosis)
Response to treatment varies.
Complications
The low blood oxygen level can cause high blood pressure in the lung blood vessels. This can lead to cor pulmonale (right-sided heart failure).
Calling your health care provider
Call for an appointment with your health care provider if symptoms of this disorder develop. Seek urgent medical care if bluish skin (cyanosis) occurs.
Prevention
There is no known prevention. Patients should avoid using sleeping medications or other medications that may cause drowsiness.
References
- Duffin J, Phillipson EA. Hypoventilation and Hyperventilation Syndromes In: Mason RJ, Broaddus CV, Martin TR, et al. Murray & Nadel's Textbook of Respiratory Medicine. 5th ed. Philadelphia, Pa: Saunders Elsevier; 2010:chap 78.
- Malhotra A. Disorders of ventilatory control. In: Goldman L, Schafer AI, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier;2011:chap 86.
Review Date: 8/30/2012.
Reviewed by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine. Denis Hadjiliadis, MD, Assistant Professor of Medicine, Division of Pulmonary, Allergy and Critical Care, University of Pennsylvania, Philadelphia, PA. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M. Health Solutions, Ebix, Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Haemodilution shows promise in decreasing blood loss and blood transfusion requirements during liver resection
Blood loss during liver resection (partial removal of liver) is one of the important factors affecting the post‐operative complications experienced by patients. Allogeneic blood transfusion (using blood donated by a different individual) is associated with increased morbidity and lower survival in patients with liver cancer. This systematic review was aimed at determining whether any cardiopulmonary intervention (interventions that change the circulation or breathing during surgery) decreased blood loss or decreased allogeneic blood transfusion requirements in patients undergoing liver resections. This review included 10 trials with 617 patients. All trials had high risk of bias (with the possibility of overestimating the benefits and underestimating the harms of the treatment) and play of chance ('random error'). The interventions included low central venous pressure (CVP; lowering the pressure in the major veins), autologous blood donation (using the patient's own blood obtained prior to liver resection), haemodilution (replacing blood with other fluids), haemodilution with controlled hypotension (lowering the blood pressure in addition to diluting the blood), and hypoventilation (decreasing the rate of artificial breathing). They were compared with controls not receiving the interventions. There were no differences in the number of deaths or complications due to surgery in any of the comparisons. Long‐term survival was not reported in any of the trials. Fewer patients required transfusion of blood donated by others when haemodilution or haemodilution with controlled hypotension were compared with a control group. The other comparisons did not decrease the transfusion requirements. However, there is a high risk of type I errors (erroneously concluding that an intervention is beneficial when it is actually not beneficial) and type II errors (erroneously concluding that an intervention is not beneficial when it is actually beneficial) because of the few trials included and the small sample size in each trial, as well as the inherent risk of bias (systematic errors which can result in overestimation of the benefits and underestimation of the harms of the intervention). Haemodilution showed promise in the reduction of blood transfusion requirements in patients undergoing liver resections. Further randomised clinical trials with low risk of bias (systematic errors) and low risk of play of chance (random errors) which assess clinically important outcomes (such as death and complications due to the operation) are necessary to assess cardiopulmonary interventions aimed at decreasing blood loss in liver resections. Trials need to be designed to assess the effect of a combination of different interventions during liver resections.
Tips for reading the newsDon’t automatically believe the headlines. Learn how to figure out which articles you’re going to believe and which you’re not.
- Primary alveolar hypoventilationPrimary alveolar hypoventilationPubMed Health
Your browsing activity is empty.
Activity recording is turned off.
See more...